Awadallah M, Idle M, Patel K, Kademani D (2018) Management update of potentially premalignant oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radiol 125:628–636. https://doi.org/10.1016/j.oooo.2018.03.010

Article  PubMed  Google Scholar 

Mello FW, Miguel AFP, Dutra KL et al (2018) Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 47:633–640. https://doi.org/10.1111/jop.12726

Article  Google Scholar 

Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E (2008) Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 37:127–133. https://doi.org/10.1111/j.1600-0714.2007.00584.x

Article  CAS  Google Scholar 

El-Naggar AK, Chan JKC, Grandis JR, et al WHO Classification of Head and Neck Tumours, 4th ed. International Agency for Research on Cancer, Lyon

Iocca O, Sollecito TP, Alawi F et al (2020) Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck 42:539–555. https://doi.org/10.1002/hed.26006

Article  PubMed  Google Scholar 

Chaturvedi AK, Udaltsova N, Engels EA et al (2020) Oral Leukoplakia and risk of progression to oral cancer: a population-based cohort study. J Natl Cancer Inst 112:1047–1054. https://doi.org/10.1093/jnci/djz238

Article  PubMed  Google Scholar 

Bouaoud J, Bossi P, Elkabets M et al (2022) Unmet needs and perspectives in oral cancer prevention. Cancers 14:1815. https://doi.org/10.3390/cancers14071815

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goossens N, Nakagawa S, Sun X, Hoshida Y (2015) Cancer biomarker discovery and validation. Transl Cancer Res 4:256–269. https://doi.org/10.3978/j.issn.2218-676X.2015.06.04

Article  CAS  PubMed  Google Scholar 

Kaur J, Matta A, Kak I et al (2014) S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Int J Cancer 134:1379–1388. https://doi.org/10.1002/ijc.28473

Article  CAS  PubMed  Google Scholar 

Hwang JTK, Gu YR, Shen M et al (2017) Individualized five-year risk assessment for oral premalignant lesion progression to cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 123:374–381. https://doi.org/10.1016/j.oooo.2016.11.004

Article  PubMed  Google Scholar 

Darling MR, Hwang JTK, Dickson BJ et al (2023) Assessing oral epithelial dysplasia risk for transformation to cancer: comparison between histologic grading systems versus S100A7 immunohistochemical signature-based grading. Appl Immunohistochem Mol Morphol AIMM 31:399–405. https://doi.org/10.1097/PAI.0000000000001132

Article  CAS  PubMed  Google Scholar 

Gu Y, Hwang JTK, Pritzker KPH, et al (2019) Automated method for assessing cancer risk using tissue samples, and system therefore. US patent US20190072559A1

Posit Team (2022) RStudio: Integrated Development Environment for R

R Core Team (2022) R: A language and environment for statistical computing

Hattinger E, Zwicker S, Ruzicka T et al (2013) Opposing functions of psoriasin (S100A7) and koebnerisin (S100A15) in epithelial carcinogenesis. Curr Opin Pharmacol 13:588–594. https://doi.org/10.1016/j.coph.2013.04.007

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tripathi SC, Matta A, Kaur J et al (2010) Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS ONE 5:e11939. https://doi.org/10.1371/journal.pone.0011939

Article  CAS  PubMed  PubMed Central  Google Scholar 

Speight PM (2007) Update on oral epithelial dysplasia and progression to cancer. Head Neck Pathol 1:61–66. https://doi.org/10.1007/s12105-007-0014-5

Article  PubMed  PubMed Central  Google Scholar 

Fleskens S, Slootweg P (2009) Grading systems in head and neck dysplasia: their prognostic value, weaknesses and utility. Head Neck Oncol 1:11. https://doi.org/10.1186/1758-3284-1-11

Article  PubMed  PubMed Central  Google Scholar 

Oral Cancer Foundation Oral Cancer Facts. Accessed June 3, 2024. https://oralcancerfoundation.org/facts/

Jacobson JJ, Epstein JB, Eichmiller FC et al (2012) The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid. Head Neck Oncol 4:15. https://doi.org/10.1186/1758-3284-4-15

Article  PubMed  PubMed Central  Google Scholar 

Buyse M, Loi S, van’t Veer L et al (2006) Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 98:1183–1192. https://doi.org/10.1093/jnci/djj329

Dubsky PC, Singer CF, Egle D et al (2020) The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial. Eur J Cancer Oxf Engl 134:99–106. https://doi.org/10.1016/j.ejca.2020.04.020

Article  CAS  Google Scholar 

Liu Y, Pan B, Xu L et al (2019) The diagnostic performance of afirma gene expression classifier for the indeterminate thyroid nodules: a meta-analysis. BioMed Res Int 2019:7150527. https://doi.org/10.1155/2019/7150527

Article  CAS  PubMed  PubMed Central  Google Scholar 

Orucevic A, Bell JL, King M et al (2019) Nomogram update based on TAILORx clinical trial results—oncotype DX breast cancer recurrence score can be predicted using clinicopathologic data. Breast Edinb Scotl 46:116–125. https://doi.org/10.1016/j.breast.2019.05.006

Article  Google Scholar